KAYTLIN HUGHES: Open Payments
NPI 1619490166 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 16 payments from 8 companies in 2025. Trend: 2023 $794 · 2024 $637 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 1 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $42 |
| Lilly USA, LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Dexcom, Inc. | 1 | $14 |
Products named: INSPIRE, FARXIGA, Kerendia, GEMTESA, MOUNJARO, Ozempic, SHINGRIX, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
